星空体育官方入口网站网址大全-登录入口官网

[GetPortalCommentsPageByObjectIdResponse(id=2147477, encodeId=95ef214e47759, content=偏重的研究方向：临床研究;胃肠肿瘤;临床 经验分享：今天收到proof,很开心，总体来说比较顺利，2023年3月24日投稿，2023年6月29日接受，小修一次，感觉难度不大，就是版面费有点贵，2890美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Tue Jul 11 13:35:21 CST 2023, time=2023-07-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2125872, encodeId=b56d21258e205, content=偏重的研究方向：肿瘤生信 经验分享：纯生信投稿接受吗？加了一小点基础实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/29/28ff84b9344976d3094a7ab4f13503a4.jpg, createdBy=30c12493504, createdName=赵荒唐, createdTime=Fri Apr 14 10:59:55 CST 2023, time=2023-04-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1078709, encodeId=7b2910e870976, content=1 Reviewer report received 29 Nov 21 投了一篇文章，这个是什么意思？收到一个人意见？还需要更多的审稿人意见再综合考虑？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0ac2780206, createdName=lihaining123, createdTime=Fri Dec 10 11:05:33 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104690, encodeId=9b9d2104690ed, content=1 reviewer reported已经快两个月了可以催吗……真的要等崩溃了，请问怎么催稿啊求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Wed Dec 07 09:14:46 CST 2022, time=2022-12-07, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2111232, encodeId=d0b9211123276, content=请问修回后editor evaluating revisions花了一周多，突然又变成2 Reviewer(s) invited是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc395402569, createdName=ms7000000473732286, createdTime=Mon Jan 23 18:16:26 CST 2023, time=2023-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1248730, encodeId=01d81248e3086, content=我的邀请了70个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Sep 13 20:53:06 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223376, encodeId=04af12233e600, content=一直是1 reviewer report recieved。何时是个头？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad788153155, createdName=ms4000000895536260, createdTime=Mon May 30 16:27:14 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113727, encodeId=736e2113e2759, content=ready for editors decision已经10天了，大家一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc395402569, createdName=ms7000000473732286, createdTime=Thu Feb 09 07:04:41 CST 2023, time=2023-02-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2155775, encodeId=5c822155e75a6, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：小白第一次投稿，结果点了预印本了，今天通知拒稿，以后去别的期刊投稿应该怎么弄啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=569f8330300, createdName=ms4000001206774480, createdTime=Sat Sep 02 15:59:30 CST 2023, time=2023-09-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154481, encodeId=e3912154481e0, content=偏重的研究方向：胃肠肿瘤;Meta分析 经验分享：外审意见回来两个审稿人意见都很积极，提了点小问题结果超级直接拒稿，既然这样还送什么外审呀，浪费时间，垃圾杂志也不知道在高贵什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Fri Aug 25 07:04:04 CST 2023, time=2023-08-25, status=1, ipAttribution=北京)]

2023-07-11 shademei 来自河北省

偏重的研究方向：临床研究;胃肠肿瘤;临床
经验分享：今天收到proof,很开心，总体来说比较顺利，2023年3月24日投稿，2023年6月29日接受，小修一次，感觉难度不大，就是版面费有点贵，2890美元

77 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2147477, encodeId=95ef214e47759, content=偏重的研究方向：临床研究;胃肠肿瘤;临床 经验分享：今天收到proof,很开心，总体来说比较顺利，2023年3月24日投稿，2023年6月29日接受，小修一次，感觉难度不大，就是版面费有点贵，2890美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Tue Jul 11 13:35:21 CST 2023, time=2023-07-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2125872, encodeId=b56d21258e205, content=偏重的研究方向：肿瘤生信 经验分享：纯生信投稿接受吗？加了一小点基础实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/29/28ff84b9344976d3094a7ab4f13503a4.jpg, createdBy=30c12493504, createdName=赵荒唐, createdTime=Fri Apr 14 10:59:55 CST 2023, time=2023-04-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1078709, encodeId=7b2910e870976, content=1 Reviewer report received 29 Nov 21 投了一篇文章，这个是什么意思？收到一个人意见？还需要更多的审稿人意见再综合考虑？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0ac2780206, createdName=lihaining123, createdTime=Fri Dec 10 11:05:33 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104690, encodeId=9b9d2104690ed, content=1 reviewer reported已经快两个月了可以催吗……真的要等崩溃了，请问怎么催稿啊求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Wed Dec 07 09:14:46 CST 2022, time=2022-12-07, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2111232, encodeId=d0b9211123276, content=请问修回后editor evaluating revisions花了一周多，突然又变成2 Reviewer(s) invited是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc395402569, createdName=ms7000000473732286, createdTime=Mon Jan 23 18:16:26 CST 2023, time=2023-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1248730, encodeId=01d81248e3086, content=我的邀请了70个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Sep 13 20:53:06 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223376, encodeId=04af12233e600, content=一直是1 reviewer report recieved。何时是个头？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad788153155, createdName=ms4000000895536260, createdTime=Mon May 30 16:27:14 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113727, encodeId=736e2113e2759, content=ready for editors decision已经10天了，大家一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc395402569, createdName=ms7000000473732286, createdTime=Thu Feb 09 07:04:41 CST 2023, time=2023-02-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2155775, encodeId=5c822155e75a6, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：小白第一次投稿，结果点了预印本了，今天通知拒稿，以后去别的期刊投稿应该怎么弄啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=569f8330300, createdName=ms4000001206774480, createdTime=Sat Sep 02 15:59:30 CST 2023, time=2023-09-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154481, encodeId=e3912154481e0, content=偏重的研究方向：胃肠肿瘤;Meta分析 经验分享：外审意见回来两个审稿人意见都很积极，提了点小问题结果超级直接拒稿，既然这样还送什么外审呀，浪费时间，垃圾杂志也不知道在高贵什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Fri Aug 25 07:04:04 CST 2023, time=2023-08-25, status=1, ipAttribution=北京)]

2023-04-14 赵荒唐来自江苏省

偏重的研究方向：肿瘤生信
经验分享：纯生信投稿接受吗？加了一小点基础实验

68 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2147477, encodeId=95ef214e47759, content=偏重的研究方向：临床研究;胃肠肿瘤;临床 经验分享：今天收到proof,很开心，总体来说比较顺利，2023年3月24日投稿，2023年6月29日接受，小修一次，感觉难度不大，就是版面费有点贵，2890美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Tue Jul 11 13:35:21 CST 2023, time=2023-07-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2125872, encodeId=b56d21258e205, content=偏重的研究方向：肿瘤生信 经验分享：纯生信投稿接受吗？加了一小点基础实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/29/28ff84b9344976d3094a7ab4f13503a4.jpg, createdBy=30c12493504, createdName=赵荒唐, createdTime=Fri Apr 14 10:59:55 CST 2023, time=2023-04-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1078709, encodeId=7b2910e870976, content=1 Reviewer report received 29 Nov 21 投了一篇文章，这个是什么意思？收到一个人意见？还需要更多的审稿人意见再综合考虑？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0ac2780206, createdName=lihaining123, createdTime=Fri Dec 10 11:05:33 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104690, encodeId=9b9d2104690ed, content=1 reviewer reported已经快两个月了可以催吗……真的要等崩溃了，请问怎么催稿啊求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Wed Dec 07 09:14:46 CST 2022, time=2022-12-07, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2111232, encodeId=d0b9211123276, content=请问修回后editor evaluating revisions花了一周多，突然又变成2 Reviewer(s) invited是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc395402569, createdName=ms7000000473732286, createdTime=Mon Jan 23 18:16:26 CST 2023, time=2023-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1248730, encodeId=01d81248e3086, content=我的邀请了70个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Sep 13 20:53:06 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223376, encodeId=04af12233e600, content=一直是1 reviewer report recieved。何时是个头？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad788153155, createdName=ms4000000895536260, createdTime=Mon May 30 16:27:14 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113727, encodeId=736e2113e2759, content=ready for editors decision已经10天了，大家一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc395402569, createdName=ms7000000473732286, createdTime=Thu Feb 09 07:04:41 CST 2023, time=2023-02-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2155775, encodeId=5c822155e75a6, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：小白第一次投稿，结果点了预印本了，今天通知拒稿，以后去别的期刊投稿应该怎么弄啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=569f8330300, createdName=ms4000001206774480, createdTime=Sat Sep 02 15:59:30 CST 2023, time=2023-09-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154481, encodeId=e3912154481e0, content=偏重的研究方向：胃肠肿瘤;Meta分析 经验分享：外审意见回来两个审稿人意见都很积极，提了点小问题结果超级直接拒稿，既然这样还送什么外审呀，浪费时间，垃圾杂志也不知道在高贵什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Fri Aug 25 07:04:04 CST 2023, time=2023-08-25, status=1, ipAttribution=北京)]

2021-12-10 lihaining123

1 Reviewer report received 29 Nov 21
投了一篇文章，这个是什么意思？收到一个人意见？还需要更多的审稿人意见再综合考虑？

145 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2147477, encodeId=95ef214e47759, content=偏重的研究方向：临床研究;胃肠肿瘤;临床 经验分享：今天收到proof,很开心，总体来说比较顺利，2023年3月24日投稿，2023年6月29日接受，小修一次，感觉难度不大，就是版面费有点贵，2890美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Tue Jul 11 13:35:21 CST 2023, time=2023-07-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2125872, encodeId=b56d21258e205, content=偏重的研究方向：肿瘤生信 经验分享：纯生信投稿接受吗？加了一小点基础实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/29/28ff84b9344976d3094a7ab4f13503a4.jpg, createdBy=30c12493504, createdName=赵荒唐, createdTime=Fri Apr 14 10:59:55 CST 2023, time=2023-04-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1078709, encodeId=7b2910e870976, content=1 Reviewer report received 29 Nov 21 投了一篇文章，这个是什么意思？收到一个人意见？还需要更多的审稿人意见再综合考虑？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0ac2780206, createdName=lihaining123, createdTime=Fri Dec 10 11:05:33 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104690, encodeId=9b9d2104690ed, content=1 reviewer reported已经快两个月了可以催吗……真的要等崩溃了，请问怎么催稿啊求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Wed Dec 07 09:14:46 CST 2022, time=2022-12-07, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2111232, encodeId=d0b9211123276, content=请问修回后editor evaluating revisions花了一周多，突然又变成2 Reviewer(s) invited是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc395402569, createdName=ms7000000473732286, createdTime=Mon Jan 23 18:16:26 CST 2023, time=2023-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1248730, encodeId=01d81248e3086, content=我的邀请了70个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Sep 13 20:53:06 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223376, encodeId=04af12233e600, content=一直是1 reviewer report recieved。何时是个头？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad788153155, createdName=ms4000000895536260, createdTime=Mon May 30 16:27:14 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113727, encodeId=736e2113e2759, content=ready for editors decision已经10天了，大家一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc395402569, createdName=ms7000000473732286, createdTime=Thu Feb 09 07:04:41 CST 2023, time=2023-02-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2155775, encodeId=5c822155e75a6, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：小白第一次投稿，结果点了预印本了，今天通知拒稿，以后去别的期刊投稿应该怎么弄啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=569f8330300, createdName=ms4000001206774480, createdTime=Sat Sep 02 15:59:30 CST 2023, time=2023-09-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154481, encodeId=e3912154481e0, content=偏重的研究方向：胃肠肿瘤;Meta分析 经验分享：外审意见回来两个审稿人意见都很积极，提了点小问题结果超级直接拒稿，既然这样还送什么外审呀，浪费时间，垃圾杂志也不知道在高贵什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Fri Aug 25 07:04:04 CST 2023, time=2023-08-25, status=1, ipAttribution=北京)]

2022-12-07 摩西摩西来自福建省

1 reviewer reported已经快两个月了可以催吗……真的要等崩溃了，请问怎么催稿啊求指点

68 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2147477, encodeId=95ef214e47759, content=偏重的研究方向：临床研究;胃肠肿瘤;临床 经验分享：今天收到proof,很开心，总体来说比较顺利，2023年3月24日投稿，2023年6月29日接受，小修一次，感觉难度不大，就是版面费有点贵，2890美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Tue Jul 11 13:35:21 CST 2023, time=2023-07-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2125872, encodeId=b56d21258e205, content=偏重的研究方向：肿瘤生信 经验分享：纯生信投稿接受吗？加了一小点基础实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/29/28ff84b9344976d3094a7ab4f13503a4.jpg, createdBy=30c12493504, createdName=赵荒唐, createdTime=Fri Apr 14 10:59:55 CST 2023, time=2023-04-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1078709, encodeId=7b2910e870976, content=1 Reviewer report received 29 Nov 21 投了一篇文章，这个是什么意思？收到一个人意见？还需要更多的审稿人意见再综合考虑？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0ac2780206, createdName=lihaining123, createdTime=Fri Dec 10 11:05:33 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104690, encodeId=9b9d2104690ed, content=1 reviewer reported已经快两个月了可以催吗……真的要等崩溃了，请问怎么催稿啊求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Wed Dec 07 09:14:46 CST 2022, time=2022-12-07, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2111232, encodeId=d0b9211123276, content=请问修回后editor evaluating revisions花了一周多，突然又变成2 Reviewer(s) invited是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc395402569, createdName=ms7000000473732286, createdTime=Mon Jan 23 18:16:26 CST 2023, time=2023-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1248730, encodeId=01d81248e3086, content=我的邀请了70个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Sep 13 20:53:06 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223376, encodeId=04af12233e600, content=一直是1 reviewer report recieved。何时是个头？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad788153155, createdName=ms4000000895536260, createdTime=Mon May 30 16:27:14 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113727, encodeId=736e2113e2759, content=ready for editors decision已经10天了，大家一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc395402569, createdName=ms7000000473732286, createdTime=Thu Feb 09 07:04:41 CST 2023, time=2023-02-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2155775, encodeId=5c822155e75a6, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：小白第一次投稿，结果点了预印本了，今天通知拒稿，以后去别的期刊投稿应该怎么弄啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=569f8330300, createdName=ms4000001206774480, createdTime=Sat Sep 02 15:59:30 CST 2023, time=2023-09-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154481, encodeId=e3912154481e0, content=偏重的研究方向：胃肠肿瘤;Meta分析 经验分享：外审意见回来两个审稿人意见都很积极，提了点小问题结果超级直接拒稿，既然这样还送什么外审呀，浪费时间，垃圾杂志也不知道在高贵什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Fri Aug 25 07:04:04 CST 2023, time=2023-08-25, status=1, ipAttribution=北京)]

2023-01-23 ms7000000473732286 来自浙江省

请问修回后editor evaluating revisions花了一周多，突然又变成2 Reviewer(s) invited是怎么回事

101 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2147477, encodeId=95ef214e47759, content=偏重的研究方向：临床研究;胃肠肿瘤;临床 经验分享：今天收到proof,很开心，总体来说比较顺利，2023年3月24日投稿，2023年6月29日接受，小修一次，感觉难度不大，就是版面费有点贵，2890美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Tue Jul 11 13:35:21 CST 2023, time=2023-07-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2125872, encodeId=b56d21258e205, content=偏重的研究方向：肿瘤生信 经验分享：纯生信投稿接受吗？加了一小点基础实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/29/28ff84b9344976d3094a7ab4f13503a4.jpg, createdBy=30c12493504, createdName=赵荒唐, createdTime=Fri Apr 14 10:59:55 CST 2023, time=2023-04-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1078709, encodeId=7b2910e870976, content=1 Reviewer report received 29 Nov 21 投了一篇文章，这个是什么意思？收到一个人意见？还需要更多的审稿人意见再综合考虑？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0ac2780206, createdName=lihaining123, createdTime=Fri Dec 10 11:05:33 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104690, encodeId=9b9d2104690ed, content=1 reviewer reported已经快两个月了可以催吗……真的要等崩溃了，请问怎么催稿啊求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Wed Dec 07 09:14:46 CST 2022, time=2022-12-07, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2111232, encodeId=d0b9211123276, content=请问修回后editor evaluating revisions花了一周多，突然又变成2 Reviewer(s) invited是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc395402569, createdName=ms7000000473732286, createdTime=Mon Jan 23 18:16:26 CST 2023, time=2023-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1248730, encodeId=01d81248e3086, content=我的邀请了70个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Sep 13 20:53:06 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223376, encodeId=04af12233e600, content=一直是1 reviewer report recieved。何时是个头？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad788153155, createdName=ms4000000895536260, createdTime=Mon May 30 16:27:14 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113727, encodeId=736e2113e2759, content=ready for editors decision已经10天了，大家一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc395402569, createdName=ms7000000473732286, createdTime=Thu Feb 09 07:04:41 CST 2023, time=2023-02-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2155775, encodeId=5c822155e75a6, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：小白第一次投稿，结果点了预印本了，今天通知拒稿，以后去别的期刊投稿应该怎么弄啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=569f8330300, createdName=ms4000001206774480, createdTime=Sat Sep 02 15:59:30 CST 2023, time=2023-09-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154481, encodeId=e3912154481e0, content=偏重的研究方向：胃肠肿瘤;Meta分析 经验分享：外审意见回来两个审稿人意见都很积极，提了点小问题结果超级直接拒稿，既然这样还送什么外审呀，浪费时间，垃圾杂志也不知道在高贵什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Fri Aug 25 07:04:04 CST 2023, time=2023-08-25, status=1, ipAttribution=北京)]

2022-09-13 xuanzixue02

我的邀请了70个审稿人

73 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2147477, encodeId=95ef214e47759, content=偏重的研究方向：临床研究;胃肠肿瘤;临床 经验分享：今天收到proof,很开心，总体来说比较顺利，2023年3月24日投稿，2023年6月29日接受，小修一次，感觉难度不大，就是版面费有点贵，2890美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Tue Jul 11 13:35:21 CST 2023, time=2023-07-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2125872, encodeId=b56d21258e205, content=偏重的研究方向：肿瘤生信 经验分享：纯生信投稿接受吗？加了一小点基础实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/29/28ff84b9344976d3094a7ab4f13503a4.jpg, createdBy=30c12493504, createdName=赵荒唐, createdTime=Fri Apr 14 10:59:55 CST 2023, time=2023-04-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1078709, encodeId=7b2910e870976, content=1 Reviewer report received 29 Nov 21 投了一篇文章，这个是什么意思？收到一个人意见？还需要更多的审稿人意见再综合考虑？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0ac2780206, createdName=lihaining123, createdTime=Fri Dec 10 11:05:33 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104690, encodeId=9b9d2104690ed, content=1 reviewer reported已经快两个月了可以催吗……真的要等崩溃了，请问怎么催稿啊求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Wed Dec 07 09:14:46 CST 2022, time=2022-12-07, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2111232, encodeId=d0b9211123276, content=请问修回后editor evaluating revisions花了一周多，突然又变成2 Reviewer(s) invited是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc395402569, createdName=ms7000000473732286, createdTime=Mon Jan 23 18:16:26 CST 2023, time=2023-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1248730, encodeId=01d81248e3086, content=我的邀请了70个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Sep 13 20:53:06 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223376, encodeId=04af12233e600, content=一直是1 reviewer report recieved。何时是个头？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad788153155, createdName=ms4000000895536260, createdTime=Mon May 30 16:27:14 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113727, encodeId=736e2113e2759, content=ready for editors decision已经10天了，大家一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc395402569, createdName=ms7000000473732286, createdTime=Thu Feb 09 07:04:41 CST 2023, time=2023-02-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2155775, encodeId=5c822155e75a6, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：小白第一次投稿，结果点了预印本了，今天通知拒稿，以后去别的期刊投稿应该怎么弄啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=569f8330300, createdName=ms4000001206774480, createdTime=Sat Sep 02 15:59:30 CST 2023, time=2023-09-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154481, encodeId=e3912154481e0, content=偏重的研究方向：胃肠肿瘤;Meta分析 经验分享：外审意见回来两个审稿人意见都很积极，提了点小问题结果超级直接拒稿，既然这样还送什么外审呀，浪费时间，垃圾杂志也不知道在高贵什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Fri Aug 25 07:04:04 CST 2023, time=2023-08-25, status=1, ipAttribution=北京)]

2022-05-30 ms4000000895536260

一直是1 reviewer report recieved。何时是个头？

90 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=2147477, encodeId=95ef214e47759, content=偏重的研究方向：临床研究;胃肠肿瘤;临床 经验分享：今天收到proof,很开心，总体来说比较顺利，2023年3月24日投稿，2023年6月29日接受，小修一次，感觉难度不大，就是版面费有点贵，2890美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Tue Jul 11 13:35:21 CST 2023, time=2023-07-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2125872, encodeId=b56d21258e205, content=偏重的研究方向：肿瘤生信 经验分享：纯生信投稿接受吗？加了一小点基础实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/29/28ff84b9344976d3094a7ab4f13503a4.jpg, createdBy=30c12493504, createdName=赵荒唐, createdTime=Fri Apr 14 10:59:55 CST 2023, time=2023-04-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1078709, encodeId=7b2910e870976, content=1 Reviewer report received 29 Nov 21 投了一篇文章，这个是什么意思？收到一个人意见？还需要更多的审稿人意见再综合考虑？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0ac2780206, createdName=lihaining123, createdTime=Fri Dec 10 11:05:33 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104690, encodeId=9b9d2104690ed, content=1 reviewer reported已经快两个月了可以催吗……真的要等崩溃了，请问怎么催稿啊求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Wed Dec 07 09:14:46 CST 2022, time=2022-12-07, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2111232, encodeId=d0b9211123276, content=请问修回后editor evaluating revisions花了一周多，突然又变成2 Reviewer(s) invited是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc395402569, createdName=ms7000000473732286, createdTime=Mon Jan 23 18:16:26 CST 2023, time=2023-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1248730, encodeId=01d81248e3086, content=我的邀请了70个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Sep 13 20:53:06 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223376, encodeId=04af12233e600, content=一直是1 reviewer report recieved。何时是个头？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad788153155, createdName=ms4000000895536260, createdTime=Mon May 30 16:27:14 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113727, encodeId=736e2113e2759, content=ready for editors decision已经10天了，大家一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc395402569, createdName=ms7000000473732286, createdTime=Thu Feb 09 07:04:41 CST 2023, time=2023-02-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2155775, encodeId=5c822155e75a6, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：小白第一次投稿，结果点了预印本了，今天通知拒稿，以后去别的期刊投稿应该怎么弄啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=569f8330300, createdName=ms4000001206774480, createdTime=Sat Sep 02 15:59:30 CST 2023, time=2023-09-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154481, encodeId=e3912154481e0, content=偏重的研究方向：胃肠肿瘤;Meta分析 经验分享：外审意见回来两个审稿人意见都很积极，提了点小问题结果超级直接拒稿，既然这样还送什么外审呀，浪费时间，垃圾杂志也不知道在高贵什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Fri Aug 25 07:04:04 CST 2023, time=2023-08-25, status=1, ipAttribution=北京)]

2023-02-09 ms7000000473732286 来自浙江省

ready for editors decision已经10天了，大家一般多久啊

69 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2147477, encodeId=95ef214e47759, content=偏重的研究方向：临床研究;胃肠肿瘤;临床 经验分享：今天收到proof,很开心，总体来说比较顺利，2023年3月24日投稿，2023年6月29日接受，小修一次，感觉难度不大，就是版面费有点贵，2890美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Tue Jul 11 13:35:21 CST 2023, time=2023-07-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2125872, encodeId=b56d21258e205, content=偏重的研究方向：肿瘤生信 经验分享：纯生信投稿接受吗？加了一小点基础实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/29/28ff84b9344976d3094a7ab4f13503a4.jpg, createdBy=30c12493504, createdName=赵荒唐, createdTime=Fri Apr 14 10:59:55 CST 2023, time=2023-04-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1078709, encodeId=7b2910e870976, content=1 Reviewer report received 29 Nov 21 投了一篇文章，这个是什么意思？收到一个人意见？还需要更多的审稿人意见再综合考虑？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0ac2780206, createdName=lihaining123, createdTime=Fri Dec 10 11:05:33 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104690, encodeId=9b9d2104690ed, content=1 reviewer reported已经快两个月了可以催吗……真的要等崩溃了，请问怎么催稿啊求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Wed Dec 07 09:14:46 CST 2022, time=2022-12-07, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2111232, encodeId=d0b9211123276, content=请问修回后editor evaluating revisions花了一周多，突然又变成2 Reviewer(s) invited是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc395402569, createdName=ms7000000473732286, createdTime=Mon Jan 23 18:16:26 CST 2023, time=2023-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1248730, encodeId=01d81248e3086, content=我的邀请了70个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Sep 13 20:53:06 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223376, encodeId=04af12233e600, content=一直是1 reviewer report recieved。何时是个头？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad788153155, createdName=ms4000000895536260, createdTime=Mon May 30 16:27:14 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113727, encodeId=736e2113e2759, content=ready for editors decision已经10天了，大家一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc395402569, createdName=ms7000000473732286, createdTime=Thu Feb 09 07:04:41 CST 2023, time=2023-02-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2155775, encodeId=5c822155e75a6, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：小白第一次投稿，结果点了预印本了，今天通知拒稿，以后去别的期刊投稿应该怎么弄啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=569f8330300, createdName=ms4000001206774480, createdTime=Sat Sep 02 15:59:30 CST 2023, time=2023-09-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154481, encodeId=e3912154481e0, content=偏重的研究方向：胃肠肿瘤;Meta分析 经验分享：外审意见回来两个审稿人意见都很积极，提了点小问题结果超级直接拒稿，既然这样还送什么外审呀，浪费时间，垃圾杂志也不知道在高贵什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Fri Aug 25 07:04:04 CST 2023, time=2023-08-25, status=1, ipAttribution=北京)]

2023-09-02 ms4000001206774480 来自山东省

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤
经验分享：小白第一次投稿，结果点了预印本了，今天通知拒稿，以后去别的期刊投稿应该怎么弄啊？

64 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2147477, encodeId=95ef214e47759, content=偏重的研究方向：临床研究;胃肠肿瘤;临床 经验分享：今天收到proof,很开心，总体来说比较顺利，2023年3月24日投稿，2023年6月29日接受，小修一次，感觉难度不大，就是版面费有点贵，2890美元, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Tue Jul 11 13:35:21 CST 2023, time=2023-07-11, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2125872, encodeId=b56d21258e205, content=偏重的研究方向：肿瘤生信 经验分享：纯生信投稿接受吗？加了一小点基础实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/11/29/28ff84b9344976d3094a7ab4f13503a4.jpg, createdBy=30c12493504, createdName=赵荒唐, createdTime=Fri Apr 14 10:59:55 CST 2023, time=2023-04-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1078709, encodeId=7b2910e870976, content=1 Reviewer report received 29 Nov 21 投了一篇文章，这个是什么意思？收到一个人意见？还需要更多的审稿人意见再综合考虑？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c0ac2780206, createdName=lihaining123, createdTime=Fri Dec 10 11:05:33 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104690, encodeId=9b9d2104690ed, content=1 reviewer reported已经快两个月了可以催吗……真的要等崩溃了，请问怎么催稿啊求指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Wed Dec 07 09:14:46 CST 2022, time=2022-12-07, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2111232, encodeId=d0b9211123276, content=请问修回后editor evaluating revisions花了一周多，突然又变成2 Reviewer(s) invited是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc395402569, createdName=ms7000000473732286, createdTime=Mon Jan 23 18:16:26 CST 2023, time=2023-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1248730, encodeId=01d81248e3086, content=我的邀请了70个审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Sep 13 20:53:06 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223376, encodeId=04af12233e600, content=一直是1 reviewer report recieved。何时是个头？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad788153155, createdName=ms4000000895536260, createdTime=Mon May 30 16:27:14 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113727, encodeId=736e2113e2759, content=ready for editors decision已经10天了，大家一般多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dc395402569, createdName=ms7000000473732286, createdTime=Thu Feb 09 07:04:41 CST 2023, time=2023-02-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2155775, encodeId=5c822155e75a6, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：小白第一次投稿，结果点了预印本了，今天通知拒稿，以后去别的期刊投稿应该怎么弄啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=569f8330300, createdName=ms4000001206774480, createdTime=Sat Sep 02 15:59:30 CST 2023, time=2023-09-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2154481, encodeId=e3912154481e0, content=偏重的研究方向：胃肠肿瘤;Meta分析 经验分享：外审意见回来两个审稿人意见都很积极，提了点小问题结果超级直接拒稿，既然这样还送什么外审呀，浪费时间，垃圾杂志也不知道在高贵什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Fri Aug 25 07:04:04 CST 2023, time=2023-08-25, status=1, ipAttribution=北京)]

2023-08-25 ms2000002077912665 来自北京

偏重的研究方向：胃肠肿瘤;Meta分析
经验分享：外审意见回来两个审稿人意见都很积极，提了点小问题结果超级直接拒稿，既然这样还送什么外审呀，浪费时间，垃圾杂志也不知道在高贵什么

63 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务